NCT07521826

Brief Summary

The primary objective of the study is to evaluate the effects of exercise on physical function, physical fitness, and body composition, with the main components including muscular strength, cardiorespiratory fitness, muscle mass, fat mass, and fat-free mass. The secondary objectives are to examine exercise adherence and the effects of exercise on health-related quality of life (HRQoL), cancer-related fatigue, and sleep quality. Additionally, the feasibility and safety of the exercise program will be assessed.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
78

participants targeted

Target at P25-P50 for not_applicable cancer

Timeline
30mo left

Started Apr 2026

Typical duration for not_applicable cancer

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress8%
Apr 2026Dec 2028

First Submitted

Initial submission to the registry

March 17, 2026

Completed
15 days until next milestone

Study Start

First participant enrolled

April 1, 2026

Completed
12 days until next milestone

First Posted

Study publicly available on registry

April 13, 2026

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2028

Expected
8 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2028

Last Updated

April 13, 2026

Status Verified

April 1, 2026

Enrollment Period

2 years

First QC Date

March 17, 2026

Last Update Submit

April 7, 2026

Conditions

Keywords

Low muscle strengthmuscle lossloss of physical functioncardiorespiratory fitnessmultimodal exercise

Outcome Measures

Primary Outcomes (3)

  • Cardiorespiratory endurance and functional capacity

    6MWT was performed as a parameter of cardiorespiratory endurance and functional capacity. Participants were instructed to walk back and forth along a flat, straight 25m corridor for six minutes, covering as much distance as possible at a self-selected pace. The total distance walked (in meters) was recorded as the primary outcome.

    Baseline and week 24 (post exercise intervention)

  • Lower-limb muscle strength

    Lower-limb muscle strength was assessed using the five-repetition sit-to-stand test (5xSTS), according to the European Working Group on Sarcopenia in Older People (EWGSOP2)¹. Participants were instructed to stand up and sit down five times as quickly as possible, with their arms crossed over the chest. The total time to complete the test was recorded in seconds (s) and used as an indicator of muscle strength. All assessments were performed by a trained evaluator

    Baseline and week 24 (post exercise intervention)

  • Handgrip strength

    Muscle strength was assessed using a handgrip dynamometer (SH5001, Saehan Grip, South Korea). Participants performed three maximal voluntary contractions with each hand in an alternating sequence, with a one-minute rest interval between trials. The highest value (kg) achieved was used for analysis. All measurements wer

    Baseline and week 24 (post exercise intervention)

Secondary Outcomes (3)

  • Body composition

    Baseline and week 24 (post exercise intervention)

  • Health-related quality of life

    Baseline and week 24 (post exercise intervention)

  • Fatigue

    Baseline and week 24 (post exercise intervention)

Study Arms (2)

Exercise group

EXPERIMENTAL

The exercise group will be instructed to complete 48 supervised, multicomponent physical training sessions over a 24-week period, with a frequency of two sessions per week on non-consecutive days.

Other: Exercise

Control group

NO INTERVENTION

Participants in the waitlist control group received standard medical care, without any exercise program or specific exercise recommendations. To maintain contact with the investigators and minimize study dropout, the waitlist control group received general health information through monthly online meetings.

Interventions

The multicomponent exercise intervention included a 10-minute warm-up consisting of balance, coordination, and stretching exercises. The main component was resistance training targeting the major muscle groups of the upper and lower body to improve strength and muscle mass. Six to eight exercises were performed using body weight, resistance bands, and dumbbells. Training progression was achieved by increasing load, repetitions, and/or sets, guided by the Borg 0-10 rating of perceived exertion scale, when health status allowed. The aerobic component consisted of walking, progressing to beginner-level running using short running intervals (50-100 m) interspersed with walking until longer continuous distances were achieved. Heart rate was monitored throughout the aerobic session.

Exercise group

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsEligibility was based on biological sex characteristics relevant to breast cancer, as this condition is directly related to the presence of breast tissue and exposure to specific hormonal factors that may influence both disease progression and responses to the proposed interventions. Therefore, inclusion criteria were defined based on essential biological characteristics to ensure sample homogeneity and the validity of the study outcomes. Gender identity was respected and recorded; however, eligibility criteria were determined by the biological characteristics required for the study.
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women aged ≥ 18 years;
  • Confirmed diagnosis of stage IV (metastatic) breast cancer;
  • Currently undergoing medical treatment;
  • Willingness and functional independence to participate in the exercise program;
  • Medical clearance to engage in structured physical exercise.

You may not qualify if:

  • Presence of unstable bone metastases.
  • Untreated or symptomatic brain metastases;
  • Evidence of severe cardiovascular disease identified by electrocardiogram (ECG);
  • Severe active infection;
  • Uncontrolled severe respiratory insufficiency or dependence on supplemental oxygen at rest or during exercise;
  • Uncontrolled severe pain;
  • Any other medical condition contraindicating participation in physical exercise;
  • Conditions that impair adherence to study procedures or the ability to provide informed consent;
  • Pregnancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universidade Estadual de Londrina, Londrina

Londrina, Paraná, 86047-597, Brazil

Location

MeSH Terms

Conditions

NeoplasmsNeoplasm MetastasisMuscular Atrophy

Interventions

Exercise

Condition Hierarchy (Ancestors)

Neoplastic ProcessesPathologic ProcessesPathological Conditions, Signs and SymptomsNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesAtrophyPathological Conditions, AnatomicalSigns and Symptoms

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Central Study Contacts

Rafael Deminice, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Participants and investigators were not blinded to group assignment, given the nature of the intervention.
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 17, 2026

First Posted

April 13, 2026

Study Start

April 1, 2026

Primary Completion (Estimated)

April 1, 2028

Study Completion (Estimated)

December 1, 2028

Last Updated

April 13, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will share

On reasonable request

Shared Documents
STUDY PROTOCOL

Locations